<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Publishing DTD v2.3 20070202//EN" "journalpublishing.dtd">
<article article-type="research-article" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xml:lang="EN">
<front>
<journal-meta>
<journal-id journal-id-type="publisher-id">Front. Surg.</journal-id>
<journal-title>Frontiers in Surgery</journal-title>
<abbrev-journal-title abbrev-type="pubmed">Front. Surg.</abbrev-journal-title>
<issn pub-type="epub">2296-875X</issn>
<publisher>
<publisher-name>Frontiers Media S.A.</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="doi">10.3389/fsurg.2025.1638820</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Surgery</subject>
<subj-group>
<subject>Original Research</subject>
</subj-group>
</subj-group>
</article-categories>
<title-group>
<article-title>Presacral tumors: a retrospective analysis of 112 cases with emphasis on diagnostic challenges and surgical outcomes</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author" equal-contrib="yes"><name><surname>Chen</surname><given-names>Shi</given-names></name>
<xref ref-type="aff" rid="aff1"><sup>1</sup></xref>
<xref ref-type="author-notes" rid="an1"><sup>&#x2020;</sup></xref><role content-type="https://credit.niso.org/contributor-roles/data-curation/"/><role content-type="https://credit.niso.org/contributor-roles/investigation/"/><role content-type="https://credit.niso.org/contributor-roles/methodology/"/><role content-type="https://credit.niso.org/contributor-roles/resources/"/><role content-type="https://credit.niso.org/contributor-roles/supervision/"/><role content-type="https://credit.niso.org/contributor-roles/validation/"/><role content-type="https://credit.niso.org/contributor-roles/visualization/"/><role content-type="https://credit.niso.org/contributor-roles/writing-original-draft/"/></contrib>
<contrib contrib-type="author" corresp="yes" equal-contrib="yes"><name><surname>Deng</surname><given-names>Heng</given-names></name>
<xref ref-type="aff" rid="aff2"><sup>2</sup></xref>
<xref ref-type="corresp" rid="cor1">&#x002A;</xref>
<xref ref-type="author-notes" rid="an1"><sup>&#x2020;</sup></xref><uri xlink:href="https://loop.frontiersin.org/people/1804340/overview"/><role content-type="https://credit.niso.org/contributor-roles/conceptualization/"/><role content-type="https://credit.niso.org/contributor-roles/data-curation/"/><role content-type="https://credit.niso.org/contributor-roles/formal-analysis/"/><role content-type="https://credit.niso.org/contributor-roles/funding-acquisition/"/><role content-type="https://credit.niso.org/contributor-roles/software/"/><role content-type="https://credit.niso.org/contributor-roles/writing-review-editing/"/></contrib>
<contrib contrib-type="author" corresp="yes"><name><surname>Li</surname><given-names>Ming</given-names></name>
<xref ref-type="aff" rid="aff3"><sup>3</sup></xref>
<xref ref-type="corresp" rid="cor1">&#x002A;</xref><uri xlink:href="https://loop.frontiersin.org/people/2554927/overview" /><role content-type="https://credit.niso.org/contributor-roles/software/"/><role content-type="https://credit.niso.org/contributor-roles/supervision/"/><role content-type="https://credit.niso.org/contributor-roles/validation/"/><role content-type="https://credit.niso.org/contributor-roles/writing-review-editing/"/></contrib>
<contrib contrib-type="author"><name><surname>Fang</surname><given-names>Xiaoli</given-names></name>
<xref ref-type="aff" rid="aff3"><sup>3</sup></xref>
<role content-type="https://credit.niso.org/contributor-roles/investigation/"/><role content-type="https://credit.niso.org/contributor-roles/writing-review-editing/"/></contrib>
</contrib-group>
<aff id="aff1"><label><sup>1</sup></label><institution>Department of Anorectal Surgery, First Clinical Medical College, Anhui University of Chinese Medicine</institution>, <addr-line>Hefei</addr-line>, <country>China</country></aff>
<aff id="aff2"><label><sup>2</sup></label><institution>Department of Anorectal Surgery, Second Affiliated Hospital, Anhui University of Chinese Medicine</institution>, <addr-line>Hefei</addr-line>, <country>China</country></aff>
<aff id="aff3"><label><sup>3</sup></label><institution>Department of Anorectal Surgery, The First Affiliated Hospital of Anhui University of Chinese Medicine</institution>, <addr-line>Hefei</addr-line>, <country>China</country></aff>
<author-notes>
<fn fn-type="edited-by"><p><bold>Edited by:</bold> <ext-link ext-link-type="uri" xlink:href="https://loop.frontiersin.org/people/1122546/overview">Gaetano Gallo</ext-link>, Vita-Salute San Raffaele University, Italy</p></fn>
<fn fn-type="edited-by"><p><bold>Reviewed by:</bold> <ext-link ext-link-type="uri" xlink:href="https://loop.frontiersin.org/people/266435/overview">Goran Zoran Stanojevi&#x0107;</ext-link>, University of Ni&#x0161;, Serbia</p>
<p><ext-link ext-link-type="uri" xlink:href="https://loop.frontiersin.org/people/1594551/overview">Bahad&#x0131;r EGE</ext-link>, At&#x0131;l&#x0131;m University, T&#x00FC;rkiye</p>
<p><ext-link ext-link-type="uri" xlink:href="https://loop.frontiersin.org/people/2900451/overview">Gianpiero Gravante</ext-link>, ASL Lecce, Italy</p>
<p><ext-link ext-link-type="uri" xlink:href="https://loop.frontiersin.org/people/3094552/overview">S&#x00FC;meyra B&#x00F6;l&#x00FC;k</ext-link>, TC Saglik Bakanligi Istanbul Sultan 2 Abdulhamid Han Egitim ve Arastirma Hastanesi, T&#x00FC;rkiye</p></fn>
<corresp id="cor1"><label>&#x002A;</label><bold>Correspondence:</bold> Ming Li <email>liming23456789@outlook.com</email> Heng Deng <email>1036019118@qq.com</email></corresp>
<fn fn-type="equal" id="an1"><label><sup>&#x2020;</sup></label><p>These authors have contributed equally to this work</p></fn>
</author-notes>
<pub-date pub-type="epub"><day>13</day><month>08</month><year>2025</year></pub-date>
<pub-date pub-type="collection"><year>2025</year></pub-date>
<volume>12</volume><elocation-id>1638820</elocation-id>
<history>
<date date-type="received"><day>31</day><month>05</month><year>2025</year></date>
<date date-type="accepted"><day>28</day><month>07</month><year>2025</year></date>
</history>
<permissions>
<copyright-statement>&#x00A9; 2025 Chen, Deng, Li and Fang.</copyright-statement>
<copyright-year>2025</copyright-year><copyright-holder>Chen, Deng, Li and Fang</copyright-holder><license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by/4.0/">
<p>This is an open-access article distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License (CC BY)</ext-link>. The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.</p></license>
</permissions>
<abstract><sec><title>Background</title>
<p>Presacral tumors are rare entities with heterogeneous pathology including malignant potential. Due to nonspecific symptoms mimicking common anorectal diseases, misdiagnosis remains a major challenge that may delay treatment and worsen prognosis, particularly for malignant variants. This study analyzes diagnostic pitfalls and surgical outcomes in a large single-center cohort.</p>
</sec><sec><title>Methods</title>
<p>We retrospectively reviewed 112 presacral tumor cases treated at our tertiary colorectal center (2015&#x2013;2025). Data included demographics, clinical presentation, misdiagnosis rates, imaging accuracy, surgical approaches, and complications. Statistical analysis utilized descriptive methods and Chi-square tests.</p>
</sec><sec><title>Results</title>
<p>Among 112 patients (male 62, female 50; median age 52 years, range 18&#x2013;93), 57&#x0025; presented with anal/rectal pain, while 20.5&#x0025; were asymptomatic. 85.7&#x0025; of patients were referred from non-specialized centers. Misdiagnosis occurred in 29.5&#x0025; (predominantly as anal fistula/abscess or pilonidal sinus). Preoperative imaging (MRI/CT) correctly diagnosed 60&#x0025; of tumors &#x003E;3&#x2005;cm vs. 21.2&#x0025; of smaller tumors (<italic>P</italic>&#x2009;&#x003C;&#x2009;0.001). Surgical approaches: 93.8&#x0025; underwent transsacral/transanal resection, 6.2&#x0025; required laparoscopic/combined abdominoperineal resection. Major complications (Clavien-Dindo grade III) occurred in 4.5&#x0025; of patients (<italic>n</italic>&#x2009;&#x003D;&#x2009;5/112), including hemorrhage, rectal injury, and sacral nerve injury. No mortality occurred. Pathology revealed 11.6&#x0025; malignancy risk.</p>
</sec><sec><title>Conclusion</title>
<p>High misdiagnosis rates (29.5&#x0025;) data support for heightened suspicion in patients with &#x201C;refractory perianal sepsis&#x201D;, especially given the potential for malignancy. MRI showed significantly higher diagnostic accuracy for tumors &#x003E;3&#x2005;cm. Transsacral/transanal resection is safe and effective for most cases (93.8&#x0025;), with low major morbidity. Centralized management in specialized centers optimizes outcomes.</p>
</sec>
</abstract>
<kwd-group>
<kwd>presacral tumor</kwd>
<kwd>surgical approach</kwd>
<kwd>case series</kwd>
<kwd>tertiary referral center</kwd>
<kwd>diagnostic error burden</kwd>
</kwd-group><contract-num rid="cn001">202427b100200</contract-num><contract-sponsor id="cn001">Clinical and Translational Research Project of Anhui Province</contract-sponsor><counts>
<fig-count count="3"/>
<table-count count="4"/><equation-count count="0"/><ref-count count="24"/><page-count count="7"/><word-count count="0"/></counts><custom-meta-wrap><custom-meta><meta-name>section-at-acceptance</meta-name><meta-value>Colorectal and Proctological Surgery</meta-value></custom-meta></custom-meta-wrap>
</article-meta>
</front>
<body><sec id="s1" sec-type="intro"><label>1</label><title>Introduction</title>
<p>Presacral tumors, arising from the retrorectal space&#x2014;a complex embryological junction containing remnants of the neural tube, notochord, and hindgut&#x2014;represent a rare yet clinically significant entity in colorectal surgery (<xref ref-type="bibr" rid="B1">1</xref>). With an estimated incidence of 1/40,000 (<xref ref-type="bibr" rid="B2">2</xref>), these lesions exhibit remarkable pathological diversity, encompassing over 25 subtypes ranging from benign cysts (e.g., tailgut cysts) to aggressive malignancies (e.g., chordomas or sarcomas) (<xref ref-type="bibr" rid="B3">3</xref>, <xref ref-type="bibr" rid="B4">4</xref>). Critically, 10&#x0025;&#x2013;30&#x0025; demonstrate malignant potential (<xref ref-type="bibr" rid="B5">5</xref>), underscoring the imperative for timely diagnosis and intervention.</p>
<p>Despite their clinical relevance, presacral tumors frequently elude early detection. Non-specific symptoms (e.g., perianal pain in 57&#x0025; of our cohort) mimic common anorectal disorders such as anal fistulas or pilonidal disease, leading to misdiagnosis rates exceeding 30&#x0025; in published series (<xref ref-type="bibr" rid="B6">6</xref>). This diagnostic delay carries profound implications: benign lesions may progress to cause irreversible nerve damage or fistulization, while malignant variants risk metastatic spread during prolonged diagnostic odysseys (<xref ref-type="bibr" rid="B7">7</xref>). Alarmingly, even at tertiary centers, over 25&#x0025; of patients present following failed prior interventions for retrorectal tumors (<xref ref-type="bibr" rid="B8">8</xref>).</p>
<p>Surgical resection remains the cornerstone of cure, yet optimal approaches are debated. The choice between transsacral, transanal, or abdominal routes hinges on tumor size, location relative to S4, and suspicion of malignancy&#x2014;factors poorly codified in current guidelines (<xref ref-type="bibr" rid="B9">9</xref>). Although minimally invasive techniques gain traction, their role in complex presacral pathology lacks robust evidence (<xref ref-type="bibr" rid="B10">10</xref>, <xref ref-type="bibr" rid="B11">11</xref>). Compounding these gaps is the scarcity of large-scale analyses: most literature comprises case report or single-institution reports with &#x003C;50 cases (<xref ref-type="bibr" rid="B12">12</xref>), insufficient to power clinical recommendations.</p>
<p>Leveraging one of Asia&#x0027;s largest presacral tumor cohorts (<italic>n</italic>&#x2009;&#x003D;&#x2009;112), this study aims to:</p>
<p>Quantify real-world misdiagnosis patterns and their impact on management timelines;</p>
<p>Evaluate imaging accuracy (MRI/CT) stratified by tumor size and pathology; Analyze surgical outcomes across approaches, emphasizing complications and recurrence; Propose a diagnostic algorithm integrating clinical red flags to mitigate delays, particularly for malignant cases. Our findings aspire to refine multidisciplinary paradigms for this orphan disease.</p>
</sec>
<sec id="s2" sec-type="methods"><label>2</label><title>Materials and methods</title>
<sec id="s2a"><label>2.1</label><title>Study design and setting</title>
<p>This retrospective cohort study adhered to the STROBE (Strengthening the Reporting of Observational Studies in Epidemiology) guidelines (<xref ref-type="bibr" rid="B13">13</xref>). We reviewed consecutive patients with histopathologically confirmed presacral tumors treated at a tertiary colorectal referral center (Department of Anorectal III, the First Clinical Medical College of Anhui University of Chinese Medicine) between January 2015 and December 2025. Ethical approval was obtained from the Institutional Review Board (No. AH012-2025), with waiver of informed consent for anonymized data.</p>
</sec>
<sec id="s2b"><label>2.2</label><title>Participants</title>
<p>We included patients &#x2265;18 years with histopathologically confirmed primary presacral tumors undergoing complete resection. Exclusion criteria were metastatic tumors and incomplete records (<xref ref-type="fig" rid="F1">Figure&#x00A0;1</xref>: STROBE patient selection flowchart).</p>
<fig id="F1" position="float"><label>Figure 1</label>
<caption><p>Patient selection flowchart (STROBE-compliant).</p></caption>
<graphic mimetype="image" mime-subtype="tiff" xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="fsurg-12-1638820-g001.tif"><alt-text content-type="machine-generated">Flowchart showing patient screening process: 130 screened patients, 18 excluded. Reasons for exclusion: 12 with metastatic tumors, 6 with incomplete data. Final cohort consists of 112 patients.</alt-text>
</graphic>
</fig>
</sec>
<sec id="s2c"><label>2.3</label><title>Data sources and variables</title>
<p>Clinical and operative data were extracted from structured electronic health records (EHR) using standardized protocols. Demographic data (age, sex, referral source) were extracted from registration records, while symptom duration and prior misdiagnoses were documented from clinic notes and referral letters. Tumor size (largest axial diameter) and radiologic suspicion of malignancy (irregular borders, diffusion restriction, or contrast enhancement) were assessed via blinded review of MRI/CT reports. Surgical approach (transsacral/transanal/abdominal) and complications were extracted from operative notes. Tumor type and malignancy confirmation (Ki-67&#x2009;&#x003E;&#x2009;20&#x0025; or lymphovascular invasion) were based on histopathology reports. 30-day morbidity (Clavien-Dindo classification) and recurrence were recorded from follow-up clinic visits.</p>
</sec>
<sec id="s2d"><label>2.4</label><title>Imaging protocols</title>
<p>MRI examinations were performed using 3&#x2005;T scanners (Philips Ingenia) with standard pelvic sequences including T1/T2-weighted imaging and diffusion-weighted imaging, with tumor malignancy suspected when demonstrating irregular borders, diffusion restriction (ADC &#x003C;1.0&#x2009;&#x00D7;&#x2009;10<sup>&#x2212;3</sup> mm<sup>2</sup>/s), or contrast enhancement. Complementary contrast-enhanced CT scans were acquired at 120&#x2005;kVp with 2&#x2005;mm slice thickness to evaluate potential bone erosion or lymphadenopathy, providing additional anatomical assessment of tumor extent and local invasion.</p>
</sec>
<sec id="s2e"><label>2.5</label><title>Bias mitigation</title>
<p>To minimize potential biases, we implemented multiple safeguards throughout the study. Misclassification bias was addressed through strict pathology confirmation protocols requiring all slides to be independently re-reviewed by specialized pathologists. Selection bias was mitigated by consecutively enrolling all eligible cases. For measurement bias control, digital rectal examination findings were standardized and performed exclusively by senior surgeons with &#x2265;10 years of clinical experience in pelvic tumor assessment.</p>
</sec>
<sec id="s2f"><label>2.6</label><title>Statistical analysis</title>
<p>Statistical analyses were performed using R version 4.1.0 (packages: stats, epiR) under the guidance of Jun Zhang, PhD from Anhui University of Chinese Medicine. Continuous variables, after confirmation of non-normality through Shapiro&#x2013;Wilk testing, were reported as medians with interquartile ranges [IQR], while categorical data were presented as counts (&#x0025;). For group comparisons, Fisher&#x0027;s exact test was employed for categorical variables with expected counts below 5, chi-square tests for larger contingency tables, and Mann&#x2013;Whitney <italic>U</italic>-tests for non-normally distributed continuous variables. Diagnostic accuracy metrics including sensitivity and specificity were calculated alongside odds ratios with 95&#x0025; confidence intervals to evaluate imaging performance. All tests were two-tailed (<italic>&#x03B1;</italic>&#x003D;0.05). No imputation was performed given &#x003C;5&#x0025; missingness (complete-case analysis).</p>
</sec>
</sec>
<sec id="s3" sec-type="results"><label>3</label><title>Results</title>
<sec id="s3a"><label>3.1</label><title>Baseline characteristics and clinical findings</title>
<p>The cohort comprised 112 patients with a median age of 52 years (range 18&#x2013;93), showing a male predominance (55.4&#x0025;, <italic>n</italic>&#x2009;&#x003D;&#x2009;62). Notably, 85.7&#x0025; (<italic>n</italic>&#x2009;&#x003D;&#x2009;96) of patients were referred from non-specialized centers, underscoring the need for centralized management of these rare tumors. The median tumor diameter was 4.2&#x2005;cm (range 0.5&#x2013;20&#x2005;cm), with 46.4&#x0025; (<italic>n</italic>&#x2009;&#x003D;&#x2009;52) measuring &#x2264;3&#x2005;cm. Interestingly, 20.5&#x0025; (<italic>n</italic>&#x2009;&#x003D;&#x2009;23) of tumors were discovered incidentally during evaluation for unrelated conditions (<xref ref-type="table" rid="T1">Table&#x00A0;1</xref>).</p>
<table-wrap id="T1" position="float"><label>Table 1</label>
<caption><p>Baseline characteristics of presacral tumor cohort [<italic>n</italic>&#x2009;&#x003D;&#x2009;112].</p></caption>
<table frame="hsides" rules="groups">
<colgroup>
<col align="left"/>
<col align="center"/>
</colgroup>
<thead>
<tr>
<th valign="top" align="left">Variable</th>
<th valign="top" align="center">Value</th>
</tr>
</thead>
<tbody>
<tr>
<td valign="top" align="left">Age (years)</td>
<td valign="top" align="center">52 [18&#x2013;93]</td>
</tr>
<tr>
<td valign="top" align="left">Sex (Male:Female)</td>
<td valign="top" align="center">62:50</td>
</tr>
<tr>
<td valign="top" align="left" colspan="2">Referral status</td>
</tr>
<tr>
<td valign="top" align="left">&#x2003;Local</td>
<td valign="top" align="center">16 (14.3&#x0025;)</td>
</tr>
<tr>
<td valign="top" align="left">&#x2003;Regional referral</td>
<td valign="top" align="center">96 (85.7&#x0025;)</td>
</tr>
<tr>
<td valign="top" align="left" colspan="2">Tumor size</td>
</tr>
<tr>
<td valign="top" align="left">&#x2003;&#x2264;3&#x2005;cm</td>
<td valign="top" align="center">52 (46.4&#x0025;)</td>
</tr>
<tr>
<td valign="top" align="left">&#x2003;&#x003E;3&#x2005;cm</td>
<td valign="top" align="center">60 (53.6&#x0025;)</td>
</tr>
<tr>
<td valign="top" align="left">Incidental finding</td>
<td valign="top" align="center">23 (20.5&#x0025;)</td>
</tr>
<tr>
<td valign="top" align="left" colspan="2">Surgical approaches</td>
</tr>
<tr>
<td valign="top" align="left">&#x2003;Transsacral</td>
<td valign="top" align="center">78.6&#x0025; (<italic>n</italic>&#x2009;&#x003D;&#x2009;88)</td>
</tr>
<tr>
<td valign="top" align="left">&#x2003;Transanal</td>
<td valign="top" align="center">15.2&#x0025; (<italic>n</italic>&#x2009;&#x003D;&#x2009;17)</td>
</tr>
<tr>
<td valign="top" align="left">&#x2003;Laparoscopic/combined</td>
<td valign="top" align="center">6.2&#x0025; (<italic>n</italic>&#x2009;&#x003D;&#x2009;7)</td>
</tr>
</tbody>
</table>
</table-wrap>
</sec>
<sec id="s3b"><label>3.2</label><title>Diagnostic performance</title>
<p>Digital rectal examination demonstrated high sensitivity (91.1&#x0025;, 102/112) for detecting presacral masses. Prior to referral, 29.5&#x0025; (<italic>n</italic>&#x2009;&#x003D;&#x2009;33) of cases had been misdiagnosed, most commonly as anal fistula (45.5&#x0025;), pilonidal sinus (30.3&#x0025;), or abscess (24.2&#x0025;). Imaging accuracy showed significant variation by tumor size, with correct preoperative diagnosis achieved in only 21.2&#x0025; of tumors &#x2264;3&#x2005;cm compared to 60&#x0025; of larger tumors (<italic>P</italic>&#x2009;&#x003C;&#x2009;0.001, <xref ref-type="table" rid="T2">Table&#x00A0;2</xref>). Among giant tumors (&#x003E;15&#x2005;cm, <italic>n</italic>&#x2009;&#x003D;&#x2009;7), preoperative MRI accurately predicted resectability in all cases, with histopathological findings revealing unexpected malignant transformation in 2 cases (28.6&#x0025;). One such case with diagnostic challenges between teratoma and primary adenocarcinoma is illustrated in <xref ref-type="fig" rid="F2">Figure&#x00A0;2</xref>.</p>
<table-wrap id="T2" position="float"><label>Table 2</label>
<caption><p>Imaging limitations by tumor size.</p></caption>
<table frame="hsides" rules="groups">
<colgroup>
<col align="left"/>
<col align="left"/>
<col align="left"/>
</colgroup>
<thead>
<tr>
<th valign="top" align="left">Size group</th>
<th valign="top" align="center">Preoperative imaging accuracy</th>
<th valign="top" align="center">Odds ratio (95&#x0025; CI)</th>
</tr>
</thead>
<tbody>
<tr>
<td valign="top" align="left">&#x003E;3&#x2005;cm</td>
<td valign="top" align="left">60.0&#x0025; (36/60)</td>
<td valign="top" align="left">4.82 (2.11&#x2013;11.02)</td>
</tr>
<tr>
<td valign="top" align="left">&#x2264;3&#x2005;cm</td>
<td valign="top" align="left">21.2&#x0025; (11/52)</td>
<td valign="top" align="left">1.00 (Reference)</td>
</tr>
<tr>
<td valign="top" align="left"><italic>P</italic>-value</td>
<td valign="top" align="left">&#x003C;0.001</td>
<td valign="top" align="left">&#x2014;</td>
</tr>
</tbody>
</table>
<table-wrap-foot>
<fn id="table-fn1"><p>Odds ratio calculated by logistic regression with &#x2264;3&#x2005;cm group as reference. Accuracy defined as correct preoperative imaging diagnoses per size group.</p></fn>
</table-wrap-foot>
</table-wrap>
<fig id="F2" position="float"><label>Figure 2</label>
<caption><p>A 31-year-old female with an asymptomatic 20&#x2009;&#x00D7;&#x2009;15&#x2005;cm presacral mass discovered incidentally and monitored for 2 years. <bold>(A)</bold> Preoperative clinical photograph (knee-chest position) demonstrating a 20&#x2009;&#x00D7;&#x2009;15&#x2005;cm sacrococcygeal mass with normal overlying skin, firm-elastic consistency, and no tenderness. <bold>(B)</bold> Preoperative sagittal T2-weighted MRI revealing a multiloculated cystic-solid mass (maximum diameter: 18.5&#x2005;cm) causing significant rectal compression. <bold>(C)</bold> Intraoperative view via sacral approach showing tumor exposure following coccygectomy (forceps indicate sacral resection margin). <bold>(D)</bold> Gross specimen (18.5&#x2009;&#x00D7;&#x2009;12.5&#x2009;&#x00D7;&#x2009;6.2&#x2005;cm) with predominant solid component (dotted line). <bold>(E)</bold> Histopathology showed diagnostic uncertainty between malignant teratoma and primary adenocarcinoma, resolved through expert consultation at our referral center. <bold>(F)</bold> Postoperative 6-month follow-up demonstrating preserved gluteal fold symmetry after reconstruction (patient consent obtained). Perineal region obscured for privacy.</p></caption>
<graphic mimetype="image" mime-subtype="tiff" xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="fsurg-12-1638820-g002.tif"><alt-text content-type="machine-generated">A collage of medical images: A shows a large mass on the lower back. B is an MRI scan showing the mass clearly. C depicts a surgical procedure with an exposed area and a ruler for scale. D displays the excised tissue with a ruler. E shows a histological slide under a microscope. F highlights the post-surgical area with a healed scar.</alt-text>
</graphic>
</fig>
</sec>
<sec id="s3c"><label>3.3</label><title>Surgical outcomes</title>
<p>Transsacral resection was performed in 78.6&#x0025; of cases (<italic>n</italic>&#x2009;&#x003D;&#x2009;88), with transanal (15.2&#x0025;, <italic>n</italic>&#x2009;&#x003D;&#x2009;17) and laparoscopic/combined approaches (6.2&#x0025;, <italic>n</italic>&#x2009;&#x003D;&#x2009;7) reserved for selected cases (<xref ref-type="table" rid="T3">Table&#x00A0;3</xref>). Major complications (Clavien-Dindo grade III) occurred in 4.5&#x0025; of patients (<italic>n</italic>&#x2009;&#x003D;&#x2009;5/112), including three cases of hemorrhage controlled with intraoperative hemostatic matrix (<italic>n</italic>&#x2009;&#x003D;&#x2009;2) or surgical packing with reoperation (<italic>n</italic>&#x2009;&#x003D;&#x2009;1), one rectal injury (&#x2264;5&#x2005;mm defect) that was primarily repaired during the procedure without diversion and managed with 5-day bowel rest followed by contrast enema confirmation, and one case of sacral nerve injury requiring postoperative neurorehabilitation. Minor complications occurred in 12.5&#x0025; (<italic>n</italic>&#x2009;&#x003D;&#x2009;14), primarily superficial wound infections treated with local care. With no mortality observed and a median follow-up of 36 months, the recurrence rate was 1.8&#x0025; (<italic>n</italic>&#x2009;&#x003D;&#x2009;2/112), both occurring in benign cystic lesions (tailgut cysts) due to incomplete epithelial removal. No malignant cases recurred, likely attributed to R0 resection&#x2009;&#x00B1;&#x2009;adjuvant therapy.</p>
<table-wrap id="T3" position="float"><label>Table 3</label>
<caption><p>Surgical approaches and outcomes (median follow-up: 36 months).</p></caption>
<table frame="hsides" rules="groups">
<colgroup>
<col align="left"/>
<col align="center"/>
<col align="left"/>
<col align="left"/>
<col align="left"/>
<col align="left"/>
<col align="left"/>
</colgroup>
<thead>
<tr>
<th valign="top" align="left">Approach</th>
<th valign="top" align="center">Cases (<italic>n</italic>&#x2009;&#x003D;&#x2009;112)</th>
<th valign="top" align="center">Ostomy rate</th>
<th valign="top" align="center">Drain use</th>
<th valign="top" align="center">Bowel prep</th>
<th valign="top" align="center">Additional maneuvers</th>
<th valign="top" align="center">Major complications</th>
</tr>
</thead>
<tbody>
<tr>
<td valign="top" align="left">Transsacral</td>
<td valign="top" align="center">88 (78.6&#x0025;)</td>
<td valign="top" align="left">0&#x0025;</td>
<td valign="top" align="left">100&#x0025;</td>
<td valign="top" align="left">20&#x0025;</td>
<td valign="top" align="left">Coccygectomy: 52.3&#x0025; (<italic>n</italic>&#x2009;&#x003D;&#x2009;46)</td>
<td valign="top" align="left">Hemorrhage: 3.4&#x0025; (<italic>n</italic>&#x2009;&#x003D;&#x2009;3)</td>
</tr>
<tr>
<td valign="top" align="left"/>
<td valign="top" align="center"/>
<td valign="top" align="left"/>
<td valign="top" align="left"/>
<td valign="top" align="left"/>
<td valign="top" align="left">Gluteal reconstruction: 3.4&#x0025; (<italic>n</italic>&#x2009;&#x003D;&#x2009;3)</td>
<td valign="top" align="left"/>
</tr>
<tr>
<td valign="top" align="left">Transanal</td>
<td valign="top" align="center">17 (15.2&#x0025;)</td>
<td valign="top" align="left">0&#x0025;</td>
<td valign="top" align="left">30&#x0025;</td>
<td valign="top" align="left">100&#x0025;</td>
<td valign="top" align="left">&#x00A0;None</td>
<td valign="top" align="left">Rectal injury: 5.9&#x0025; (<italic>n</italic>&#x2009;&#x003D;&#x2009;1);</td>
</tr>
<tr>
<td valign="top" align="left">Laparoscopic</td>
<td valign="top" align="center">7 (6.2&#x0025;)</td>
<td valign="top" align="left">2 (28.6&#x0025;)&#x002A;</td>
<td valign="top" align="left">100&#x0025;</td>
<td valign="top" align="left">100&#x0025;</td>
<td valign="top" align="left">&#x00A0;None</td>
<td valign="top" align="left">Nerve Injury: 14.3&#x0025; (<italic>n</italic>&#x2009;&#x003D;&#x2009;1)</td>
</tr>
</tbody>
</table>
<table-wrap-foot>
<fn id="table-fn2"><p>&#x002A;Footnotes: Both ostomies were temporary (diverting ileostomies for rectal injury repair).</p></fn>
<fn id="table-fn3"><p>Major complications management: Hemorrhage (<italic>n</italic>&#x2009;&#x003D;&#x2009;3): Hemostatic matrix (<italic>n</italic>&#x2009;&#x003D;&#x2009;2), reoperation (<italic>n</italic>&#x2009;&#x003D;&#x2009;1); Rectal injury (<italic>n</italic>&#x2009;&#x003D;&#x2009;1): Primary repair, no diversion; Nerve injury (<italic>n</italic>&#x2009;&#x003D;&#x2009;1): Neurorehabilitation.&#x201D;.</p></fn>
</table-wrap-foot>
</table-wrap>
<sec id="s3c1"><label>3.3.4</label><title>Pathologic subgroup analysis</title>
<p>Malignant tumors showed distinct management patterns compared to benign cases. Among the 13 malignant tumors, 5 required laparoscopic or combined surgical approaches. The treatment strategy for benign tumors was predominantly transsacral or transanal resection (97/99), with only 2 cases requiring laparoscopic/combined approaches. Adjuvant therapy was administered in 7 of the 13 malignant cases. Diagnostic challenges were more pronounced in malignant tumors, with 38.5&#x0025; (5/13) receiving initial misdiagnosis vs. 28.3&#x0025; (28/99) of benign cases.</p>
</sec>
</sec>
</sec>
<sec id="s4" sec-type="discussion"><label>4</label><title>Discussion</title>
<p>Our study of 112 presacral tumors highlights persistent diagnostic delays, with 29.5&#x0025; of cases initially misdiagnosed as benign anorectal disorders&#x2014;a finding consistent with prior reports (25&#x0025;&#x2013;40&#x0025;) (<xref ref-type="bibr" rid="B14">14</xref>). The asymptomatic nature of 20.5&#x0025; of tumors emerged as a significant contributor to delayed detection (<xref ref-type="bibr" rid="B15">15</xref>). This contrasts with symptomatic presentations where pain typically prompts timely imaging. Digital rectal examination (DRE) demonstrated particular value, detecting 91.1&#x0025; of masses, reinforcing its underutilized role in primary care screening (<xref ref-type="bibr" rid="B16">16</xref>): Digital rectal exam is the cheapest and most effective screening tool for presacral pathology.</p>
<p>In our cohort, stratification by tumor diameter revealed a significant detection threshold at 3&#x2005;cm, with diagnostic accuracy markedly lower for tumors &#x2264;3&#x2005;cm (21.2&#x0025;) compared to larger tumors (60.0&#x0025;; OR&#x2009;&#x003D;&#x2009;4.82, 95&#x0025;CI 2.11&#x2013;11.02, <italic>P</italic>&#x2009;&#x003C;&#x2009;0.001). MRI&#x0027;s limited resolution for minute lesions (&#x003C;2&#x2005;cm) and radiologists&#x2019; unfamiliarity with rare presacral variants compound this (<xref ref-type="bibr" rid="B17">17</xref>). Moreover, the tumor diameters of our malignant cases are all greater than this threshold. Prior studies indicate tumors &#x003E;3&#x2005;cm are more likely to exhibit malignant features (<xref ref-type="bibr" rid="B5">5</xref>). Our data reinforce proposal: Pelvic MRI for atypical fistulas (failed &#x003E;1 surgery), Non-palpable masses with persistent symptoms, any presacral lesion &#x003E;2&#x2005;cm on digital rectal exam.</p>
<p>The transsacral approach emerged as the predominant surgical strategy (78.6&#x0025; of cases), demonstrating both safety (4.5&#x0025; major morbidity) and versatility across diverse pathologies. Our utilization rate exceeds historical series (40&#x0025;&#x2013;70&#x0025;) (<xref ref-type="bibr" rid="B9">9</xref>, <xref ref-type="bibr" rid="B18">18</xref>), reflecting both technical refinements (e.g., coccygectomy in 41.1&#x0025; of cases) and careful patient selection. For complex malignancies, laparoscopic/combined approaches proved valuable, particularly for hemorrhage control (<xref ref-type="bibr" rid="B19">19</xref>). Technical improvements include coccygectomy and gluteal reconstruction reduced recurrence and functional deficits, addressing historic concerns of poor wound healing (<xref ref-type="bibr" rid="B20">20</xref>). Technical Recommendations from High-Volume Experience: First, Incision planning: For transsacral resection, a curvilinear incision 2&#x2005;cm lateral to the coccyx avoids midline wound tension; Second, Drain placement: Closed suction drains were routinely used for tumors &#x003E;5&#x2005;cm; Third, Bowel preparation: Limited to cases with suspected rectal invasion (15&#x0025;), aligning with enhanced recovery protocols. Similar to the findings by Mente&#x015F; et al. in a Turkish cohort (<xref ref-type="bibr" rid="B21">21</xref>).</p>
<p>Diagnostic Red Flags (<xref ref-type="fig" rid="F3">Figure&#x00A0;3</xref>): The high misdiagnosis rate our data support the use of pelvic MRI in cases of refractory perianal sepsis, even without palpable masses. Our proposed 3-cm imaging threshold mandates closer surveillance for small tumors. Centralized Care Model: 85.7&#x0025; of patients were referred from underserved areas, referral rate confirms regional demand for specialized management, echoing NCCN guidelines for rare tumors (<xref ref-type="bibr" rid="B22">22</xref>), consistent with global disparities in pelvic tumor care (<xref ref-type="bibr" rid="B8">8</xref>). Our experience highlights the diagnostic challenges posed by presacral tumors&#x2019; embryological complexity (<xref ref-type="table" rid="T4">Table&#x00A0;4</xref>), exemplified by the malignant teratoma case where immunohistochemical markers (CDX2&#x002B;/CK20&#x002B;) failed to resolve the pathological dichotomy between malignant teratoma transformation (<xref ref-type="bibr" rid="B23">23</xref>), and tailgut origin theories (<xref ref-type="bibr" rid="B24">24</xref>). This underscores our recommendation for mandatory secondary pathological review in malignant cases.</p>
<fig id="F3" position="float"><label>Figure 3</label>
<caption><p>Diagnostic algorithm for suspected presacral tumors.</p></caption>
<graphic mimetype="image" mime-subtype="tiff" xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="fsurg-12-1638820-g003.tif"><alt-text content-type="machine-generated">Flowchart outlining the process for assessing tumor size. Two conditions, \"Refractory 'anal fistula'\" and \"Asymptomatic presacral mass,\" lead to an MRI pelvis. The MRI assesses tumor size, resulting in either a specialist referral if size is unsupported, or a three-month MRI follow-up if the tumor is 3 centimeters or smaller.</alt-text>
</graphic>
</fig>
<table-wrap id="T4" position="float"><label>Table 4</label>
<caption><p>Histopathological diagnoses and malignancy rates.</p></caption>
<table frame="hsides" rules="groups">
<colgroup>
<col align="left"/>
<col align="center"/>
<col align="center"/>
</colgroup>
<thead>
<tr>
<th valign="top" align="left">Pathological diagnosis</th>
<th valign="top" align="center">Total cases (<italic>n</italic>&#x2009;&#x003D;&#x2009;112)</th>
<th valign="top" align="center">Malignant cases (&#x0025;)&#x002A;</th>
</tr>
</thead>
<tbody>
<tr>
<td valign="top" align="left">Neuroendocrine tumors</td>
<td valign="top" align="center">36</td>
<td valign="top" align="center">5 (13.9&#x0025;)</td>
</tr>
<tr>
<td valign="top" align="left">Gastrointestinal stromal tumors (GIST)</td>
<td valign="top" align="center">24</td>
<td valign="top" align="center">3 (12.5&#x0025;)</td>
</tr>
<tr>
<td valign="top" align="left">Epidermoid cysts</td>
<td valign="top" align="center">19</td>
<td valign="top" align="center">0 (0&#x0025;)</td>
</tr>
<tr>
<td valign="top" align="left">Tailgut cysts</td>
<td valign="top" align="center">12</td>
<td valign="top" align="center">0 (0&#x0025;)</td>
</tr>
<tr>
<td valign="top" align="left">Chordomas</td>
<td valign="top" align="center">2</td>
<td valign="top" align="center">2 (100&#x0025;)</td>
</tr>
<tr>
<td valign="top" align="left">Teratomas</td>
<td valign="top" align="center">2</td>
<td valign="top" align="center">1 (50&#x0025;)</td>
</tr>
<tr>
<td valign="top" align="left">Hamartomas</td>
<td valign="top" align="center">8</td>
<td valign="top" align="center">0 (0&#x0025;)</td>
</tr>
<tr>
<td valign="top" align="left">Schwannomas</td>
<td valign="top" align="center">1</td>
<td valign="top" align="center">0 (0&#x0025;)</td>
</tr>
<tr>
<td valign="top" align="left">Neurofibromas</td>
<td valign="top" align="center">1</td>
<td valign="top" align="center">0 (0&#x0025;)</td>
</tr>
<tr>
<td valign="top" align="left">Fibromas</td>
<td valign="top" align="center">5</td>
<td valign="top" align="center">0 (0&#x0025;)</td>
</tr>
<tr>
<td valign="top" align="left">Lymphomas</td>
<td valign="top" align="center">2</td>
<td valign="top" align="center">2 (100&#x0025;)</td>
</tr>
<tr>
<td valign="top" align="left">Total</td>
<td valign="top" align="center">112</td>
<td valign="top" align="center">13 (11.6&#x0025;)</td>
</tr>
</tbody>
</table>
<table-wrap-foot>
<fn id="table-fn4"><p>&#x002A;Malignant transformation confirmed by Ki-67&#x2009;&#x003E;&#x2009;20&#x0025; and lymphovascular invasion.</p></fn>
</table-wrap-foot>
</table-wrap>
<p>Although, this study benefits from its large cohort of 112 cases. However, the retrospective design introduces potential selection bias, and while the high referral rate partially offsets the single-center limitation, the findings may not be fully generalizable. Additionally, the median 36-month follow-up period restricts assessment of long-term outcomes for malignant subtypes, suggesting need for extended surveillance in future studies. Future work should establish multicenter registries for malignant variants, explore PET-CT&#x0027;s role in &#x2264;3&#x2005;cm tumors, compare robotic vs. open approaches for complex cases.</p>
</sec>
<sec id="s5" sec-type="conclusions"><label>5</label><title>Conclusions</title>
<p>This large-scale analysis of 112 presacral tumors establishes three critical practice-changing conclusions: First, the persistent misdiagnosis rate and atypical fistulas mandates routine pelvic MRI for refractory perianal cases, particularly given the 11.6&#x0025; malignancy risk. Second, the transsacral approach demonstrated both dominance (78.6&#x0025; utilization) and safety (4.5&#x0025; major morbidity), confirming its role as the first-line strategy for presacral Tumors. Most significantly, our 85.7&#x0025; referral rate and diagnostic challenges underscore that they require centralized multidisciplinary team management to optimize outcomes, reinforcing the need for regional referral networks in managing these complex tumors.</p>
</sec>
</body>
<back>
<sec id="s6" sec-type="data-availability"><title>Data availability statement</title>
<p>The datasets presented in this study can be found in online repositories. The names of the repository/repositories and accession number(s) can be found below: Data Availability Statement: <ext-link ext-link-type="uri" xlink:href="https://www.jianguoyun.com/p/DX8Q-X0Ql7C8DRjx6_sFIAA">https://www.jianguoyun.com/p/DX8Q-X0Ql7C8DRjx6_sFIAA</ext-link>.</p>
</sec>
<sec id="s7" sec-type="ethics-statement"><title>Ethics statement</title>
<p>The studies involving humans were approved by Pathological re-review protocol was approved under IRB No. AH012-2025. The studies were conducted in accordance with the local legislation and institutional requirements. The participants provided their written informed consent to participate in this study. Written informed consent was obtained from the individual(s) for the publication of any potentially identifiable images or data included in this article.</p>
</sec>
<sec id="s8" sec-type="author-contributions"><title>Author contributions</title>
<p>SC: Data curation, Investigation, Methodology, Resources, Supervision, Validation, Visualization, Writing &#x2013; original draft. HD: Conceptualization, Data curation, Formal analysis, Funding acquisition, Software, Writing &#x2013; review &#x0026; editing. ML: Software, Supervision, Validation, Writing &#x2013; review &#x0026; editing. XF: Investigation, Writing &#x2013; review &#x0026; editing.</p>
</sec>
<sec id="s9" sec-type="funding-information"><title>Funding</title>
<p>The author(s) declare that financial support was received for the research and/or publication of this article. This work was supported by the Clinical and Translational Research Project of Anhui Province (Grant No. 202427b100200).</p>
</sec>
<ack><title>Acknowledgments</title>
<p>We thank Jun Zhang, PhD, Anhui University of Chinese Medicine, for statistical advice and analysis support.</p>
</ack>
<sec id="s10" sec-type="COI-statement"><title>Conflict of interest</title>
<p>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</p>
</sec>
<sec id="s11" sec-type="ai-statement"><title>Generative AI statement</title>
<p>The author(s) declare that no Generative AI was used in the creation of this manuscript.</p>
<p>Any alternative text (alt text) provided alongside figures in this article has been generated by Frontiers with the support of artificial intelligence and reasonable efforts have been made to ensure accuracy, including review by the authors wherever possible. If you identify any issues, please contact us.</p>
</sec>
<sec id="s12" sec-type="disclaimer"><title>Publisher&#x0027;s note</title>
<p>All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.</p>
</sec>
<ref-list><title>References</title>
<ref id="B1"><label>1.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>G</given-names></name><name><surname>Miao</surname><given-names>C</given-names></name></person-group>. <article-title>Chinese Expert consensus on standardized treatment for presacral cysts</article-title>. <source>Gastroenterol Rep (Oxf)</source>. (<year>2023</year>) <volume>11</volume>:<fpage>goac079</fpage>. <pub-id pub-id-type="doi">10.1093/gastro/goac079</pub-id><pub-id pub-id-type="pmid">37655176</pub-id></citation></ref>
<ref id="B2"><label>2.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Jones</surname><given-names>M</given-names></name><name><surname>Khosa</surname><given-names>J</given-names></name></person-group>. <article-title>Presacral tumours: a rare case of a dermoid cyst in a paediatric patient</article-title>. <source>BMJ Case Rep</source>. (<year>2013</year>) <volume>2013</volume>:<fpage>bcr2013008783</fpage>. <pub-id pub-id-type="doi">10.1136/bcr-2013-008783</pub-id><pub-id pub-id-type="pmid">23682084</pub-id></citation></ref>
<ref id="B3"><label>3.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Lev-Chelouche</surname><given-names>D</given-names></name><name><surname>Gutman</surname><given-names>M</given-names></name><name><surname>Goldman</surname><given-names>G</given-names></name><name><surname>Even-Sapir</surname><given-names>E</given-names></name><name><surname>Meller</surname><given-names>I</given-names></name><name><surname>Issakov</surname><given-names>J</given-names></name><etal/></person-group> <article-title>Presacral tumors: a practical classification and treatment of a unique and heterogeneous group of diseases</article-title>. <source>Surgery</source>. (<year>2003</year>) <volume>133</volume>(<issue>5</issue>):<fpage>473</fpage>&#x2013;<lpage>8</lpage>. <pub-id pub-id-type="doi">10.1067/msy.2003.118</pub-id><pub-id pub-id-type="pmid">12773974</pub-id></citation></ref>
<ref id="B4"><label>4.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Pascual</surname><given-names>JFR</given-names></name><name><surname>Alonso</surname><given-names>EA</given-names></name><name><surname>Perez</surname><given-names>LP</given-names></name><name><surname>Rico</surname><given-names>MA</given-names></name></person-group>. <article-title>Adenocarcinoma on retrorectal cystic hamartoma: an illustrative image for a very rare diagnosis</article-title>. <source>Semin Oncol</source>. (<year>2024</year>) <volume>51</volume>(<issue>5-6</issue>):<fpage>154</fpage>&#x2013;<lpage>5</lpage>. <pub-id pub-id-type="doi">10.1053/j.seminoncol.2024.10.003</pub-id><pub-id pub-id-type="pmid">39542812</pub-id></citation></ref>
<ref id="B5"><label>5.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Baek</surname><given-names>SK</given-names></name><name><surname>Hwang</surname><given-names>GS</given-names></name><name><surname>Vinci</surname><given-names>A</given-names></name><name><surname>Jafari</surname><given-names>MD</given-names></name><name><surname>Jafari</surname><given-names>F</given-names></name><name><surname>Moghadamyeghaneh</surname><given-names>Z</given-names></name><etal/></person-group> <article-title>Retrorectal tumors: a comprehensive literature review</article-title>. <source>World J Surg</source>. (<year>2016</year>) <volume>40</volume>(<issue>8</issue>):<fpage>2001</fpage>&#x2013;<lpage>15</lpage>. <pub-id pub-id-type="doi">10.1007/s00268-016-3501-6</pub-id><pub-id pub-id-type="pmid">27083451</pub-id></citation></ref>
<ref id="B6"><label>6.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>YS</given-names></name><name><surname>Guo</surname><given-names>QY</given-names></name><name><surname>Zheng</surname><given-names>FH</given-names></name><name><surname>Huang</surname><given-names>ZW</given-names></name><name><surname>Yan</surname><given-names>JL</given-names></name><name><surname>Fan</surname><given-names>FX</given-names></name><etal/></person-group> <article-title>Retrorectal mucinous adenocarcinoma arising from a tailgut cyst: a case report and review of literature</article-title>. <source>World J Gastrointest Surg</source>. (<year>2022</year>) <volume>14</volume>(<issue>9</issue>):<fpage>1072</fpage>&#x2013;<lpage>81</lpage>. <pub-id pub-id-type="doi">10.4240/wjgs.v14.i9.1072</pub-id><pub-id pub-id-type="pmid">36185552</pub-id></citation></ref>
<ref id="B7"><label>7.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Suresh</surname><given-names>R</given-names></name><name><surname>Shankar</surname><given-names>SV</given-names></name></person-group>. <article-title>An unusual perianal presentation of a tailgut cyst</article-title>. <source>Cureus</source>. (<year>2022</year>) <volume>14</volume>(<issue>5</issue>):<fpage>e24953</fpage>. <pub-id pub-id-type="doi">10.7759/cureus.24953</pub-id><pub-id pub-id-type="pmid">35706752</pub-id></citation></ref>
<ref id="B8"><label>8.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Chung</surname><given-names>JS</given-names></name><name><surname>Kwak</surname><given-names>HD</given-names></name><name><surname>Ju</surname><given-names>JK</given-names></name></person-group>. <article-title>Laparoscopic approach in the surgical treatment of large retrorectal tumors: a short-term experience at a single tertiary center case series in Korea</article-title>. <source>J Minimal Invas Surg</source>. (<year>2024</year>) <volume>27</volume>(<issue>4</issue>):<fpage>221</fpage>&#x2013;<lpage>6</lpage>. <pub-id pub-id-type="doi">10.7602/jmis.2024.27.4.221</pub-id></citation></ref>
<ref id="B9"><label>9.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Fechner</surname><given-names>K</given-names></name><name><surname>Bittorf</surname><given-names>B</given-names></name><name><surname>Langheinrich</surname><given-names>M</given-names></name><name><surname>Weber</surname><given-names>K</given-names></name><name><surname>Brunner</surname><given-names>M</given-names></name><name><surname>Grutzmann</surname><given-names>R</given-names></name><etal/></person-group> <article-title>The management of retrorectal tumors&#x2014;a single-center analysis of 21 cases and overview of the literature</article-title>. <source>Langenbeck&#x2019;s Arch Surg</source>. (<year>2024</year>) <volume>409</volume>(<issue>1</issue>):<fpage>279</fpage>. <pub-id pub-id-type="doi">10.1007/s00423-024-03471-0</pub-id></citation></ref>
<ref id="B10"><label>10.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Kiosov</surname><given-names>O</given-names></name><name><surname>Tkachov</surname><given-names>V</given-names></name><name><surname>Gulevskyi</surname><given-names>S</given-names></name></person-group>. <article-title>Endoscopic resection of tailgut cyst</article-title>. <source>Case Rep Gastrointest Med</source>. (<year>2024</year>) <volume>2024</volume>:<fpage>5538439</fpage>. <pub-id pub-id-type="doi">10.1155/2024/5538439</pub-id><pub-id pub-id-type="pmid">38939693</pub-id></citation></ref>
<ref id="B11"><label>11.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Garcia Mora</surname><given-names>M</given-names></name><name><surname>Marino</surname><given-names>IF</given-names></name><name><surname>Puerto Horta</surname><given-names>LJ</given-names></name><name><surname>Gonzalez</surname><given-names>F</given-names></name><name><surname>Diaz Casas</surname><given-names>S</given-names></name></person-group>. <article-title>The surgical approach combined with minimally invasive surgery for sacral chordoma</article-title>. <source>Cureus</source>. (<year>2021</year>) <volume>13</volume>(<issue>10</issue>):<fpage>e18690</fpage>. <pub-id pub-id-type="doi">10.7759/cureus.18690</pub-id><pub-id pub-id-type="pmid">34786264</pub-id></citation></ref>
<ref id="B12"><label>12.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Li</surname><given-names>S</given-names></name><name><surname>Wu</surname><given-names>G</given-names></name><name><surname>Gu</surname><given-names>X</given-names></name><name><surname>Zhang</surname><given-names>D</given-names></name><name><surname>Zheng</surname><given-names>X</given-names></name></person-group>. <article-title>Surgical treatment of giant sacral terminal filar cysts: a case report and review of the literature</article-title>. <source>J Med Case Rep</source>. (<year>2025</year>) <volume>19</volume>(<issue>1</issue>):<fpage>246</fpage>. <pub-id pub-id-type="doi">10.1186/s13256-025-05306-y</pub-id><pub-id pub-id-type="pmid">40405301</pub-id></citation></ref>
<ref id="B13"><label>13.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Skrivankova</surname><given-names>VW</given-names></name><name><surname>Richmond</surname><given-names>RC</given-names></name><name><surname>Woolf</surname><given-names>BAR</given-names></name><name><surname>Yarmolinsky</surname><given-names>J</given-names></name><name><surname>Davies</surname><given-names>NM</given-names></name><name><surname>Swanson</surname><given-names>SA</given-names></name><etal/></person-group> <article-title>Strengthening the reporting of observational studies in epidemiology using Mendelian randomization: the STROBE-MR statement</article-title>. <source>JAMA</source>. (<year>2021</year>) <volume>326</volume>(<issue>16</issue>):<fpage>1614</fpage>&#x2013;<lpage>21</lpage>. <pub-id pub-id-type="doi">10.1001/jama.2021.18236</pub-id><pub-id pub-id-type="pmid">34698778</pub-id></citation></ref>
<ref id="B14"><label>14.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Shah</surname><given-names>N</given-names></name><name><surname>Edelstein</surname><given-names>P</given-names></name></person-group>. <article-title>Retrorectal tailgut cyst: a case report</article-title>. <source>Cureus</source>. (<year>2022</year>) <volume>14</volume>(<issue>3</issue>):<fpage>e23319</fpage>. <pub-id pub-id-type="doi">10.7759/cureus.23319</pub-id><pub-id pub-id-type="pmid">35464523</pub-id></citation></ref>
<ref id="B15"><label>15.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Ghannouchi</surname><given-names>M</given-names></name><name><surname>Khalifa</surname><given-names>MB</given-names></name><name><surname>Zoukar</surname><given-names>O</given-names></name><name><surname>Nacef</surname><given-names>K</given-names></name><name><surname>Chakka</surname><given-names>A</given-names></name><name><surname>Boudokhan</surname><given-names>M</given-names></name></person-group>. <article-title>Retrorectal epidermoid mistaken for perirectal swelling: a case report</article-title>. <source>Int J Surg Case Rep</source>. (<year>2022</year>) <volume>95</volume>:<fpage>107187</fpage>. <pub-id pub-id-type="doi">10.1016/j.ijscr.2022.107187</pub-id><pub-id pub-id-type="pmid">35569309</pub-id></citation></ref>
<ref id="B16"><label>16.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Pidala</surname><given-names>MJ</given-names></name><name><surname>Eisenstat</surname><given-names>TE</given-names></name><name><surname>Rubin</surname><given-names>RJ</given-names></name><name><surname>Salvati</surname><given-names>EP</given-names></name></person-group>. <article-title>Presacral cysts: transrectal excision in select patients</article-title>. <source>Am Surg</source>. (<year>1999</year>) <volume>65</volume>(<issue>2</issue>):<fpage>112</fpage>&#x2013;<lpage>5</lpage>. <pub-id pub-id-type="doi">10.1177/000313489906500203</pub-id><pub-id pub-id-type="pmid">9926741</pub-id></citation></ref>
<ref id="B17"><label>17.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Patel</surname><given-names>N</given-names></name><name><surname>Maturen</surname><given-names>KE</given-names></name><name><surname>Kaza</surname><given-names>RK</given-names></name><name><surname>Gandikota</surname><given-names>G</given-names></name><name><surname>Al-Hawary</surname><given-names>MM</given-names></name><name><surname>Wasnik</surname><given-names>AP</given-names></name></person-group>. <article-title>Imaging of presacral masses&#x2013;a multidisciplinary approach</article-title>. <source>Br J Radiol</source>. (<year>2016</year>) <volume>89</volume>(<issue>1061</issue>):<fpage>20150698</fpage>. <pub-id pub-id-type="doi">10.1259/bjr.20150698</pub-id><pub-id pub-id-type="pmid">26828969</pub-id></citation></ref>
<ref id="B18"><label>18.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Ren</surname><given-names>K</given-names></name><name><surname>Fan</surname><given-names>GT</given-names></name><name><surname>Zhou</surname><given-names>ZW</given-names></name><name><surname>Wu</surname><given-names>SJ</given-names></name><name><surname>Shi</surname><given-names>X</given-names></name><name><surname>Lu</surname><given-names>J</given-names></name></person-group>. <article-title>Surgical management of sacral neurogenic tumors</article-title>. <source>Zhongguo Gu Shang</source>. (<year>2022</year>) <volume>35</volume>(<issue>5</issue>):<fpage>470</fpage>&#x2013;<lpage>5</lpage>. <pub-id pub-id-type="doi">10.12200/j.issn.1003-0034.2022.05.012</pub-id><pub-id pub-id-type="pmid">35535537</pub-id></citation></ref>
<ref id="B19"><label>19.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Sarhan</surname><given-names>K</given-names></name><name><surname>Serag</surname><given-names>I</given-names></name><name><surname>Sabry</surname><given-names>A</given-names></name><name><surname>Elghareeb</surname><given-names>H</given-names></name><name><surname>Shahein</surname><given-names>M</given-names></name></person-group>. <article-title>Presentation and surgical management approaches of giant presacral and sacral schwannomas: a case report and systematic review and meta-analysis</article-title>. <source>Europ Spine J</source>. (<year>2025</year>) <volume>34</volume>(<issue>3</issue>):<fpage>874</fpage>&#x2013;<lpage>86</lpage>. <pub-id pub-id-type="doi">10.1007/s00586-024-08641-8</pub-id></citation></ref>
<ref id="B20"><label>20.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Cini</surname><given-names>C</given-names></name><name><surname>Asunis</surname><given-names>E</given-names></name><name><surname>Griffoni</surname><given-names>C</given-names></name><name><surname>Evangelisti</surname><given-names>G</given-names></name><name><surname>Tedesco</surname><given-names>G</given-names></name><name><surname>Ghermandi</surname><given-names>R</given-names></name><etal/></person-group> <article-title>Surgical management of sacral bone tumors: a retrospective analysis of outcomes, complications, and survival</article-title>. <source>Diagnostics</source>. (<year>2025</year>) <volume>15</volume>(<issue>7</issue>):<fpage>917</fpage>. <pub-id pub-id-type="doi">10.3390/diagnostics15070917</pub-id><pub-id pub-id-type="pmid">40218267</pub-id></citation></ref>
<ref id="B21"><label>21.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Mentes</surname><given-names>BB</given-names></name><name><surname>Kurukahvecioglu</surname><given-names>O</given-names></name><name><surname>Ege</surname><given-names>B</given-names></name><name><surname>Karamercan</surname><given-names>A</given-names></name><name><surname>Leventoglu</surname><given-names>S</given-names></name><name><surname>Yazicioglu</surname><given-names>O</given-names></name><etal/></person-group> <article-title>Retrorectal tumors: a case series</article-title>. <source>Turk J Gastroenterol</source>. (<year>2008</year>) <volume>19</volume>(<issue>1</issue>):<fpage>40</fpage>&#x2013;<lpage>4</lpage>.<pub-id pub-id-type="pmid">18386239</pub-id></citation></ref>
<ref id="B22"><label>22.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>von Mehren</surname><given-names>M</given-names></name><name><surname>Kane</surname><given-names>JM</given-names></name><name><surname>Riedel</surname><given-names>RF</given-names></name><name><surname>Sicklick</surname><given-names>JK</given-names></name><name><surname>Pollack</surname><given-names>SM</given-names></name><name><surname>Agulnik</surname><given-names>M</given-names></name><etal/></person-group> <article-title>NCCN Guidelines(R) insights: gastrointestinal stromal tumors, version 2.2022</article-title>. <source>J Nat Comprehen Cancer Netw</source>. (<year>2022</year>) <volume>20</volume>(<issue>11</issue>):<fpage>1204</fpage>&#x2013;<lpage>14</lpage>. <pub-id pub-id-type="doi">10.6004/jnccn.2022.0058</pub-id></citation></ref>
<ref id="B23"><label>23.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Awad Hegazy</surname><given-names>A</given-names></name><name><surname>Ibraheem Al-Qtaitat</surname><given-names>A</given-names></name><name><surname>Awad Hegazy</surname><given-names>R</given-names></name></person-group>. <article-title>A new hypothesis may explain human parthenogenesis and ovarian teratoma: a review study</article-title>. <source>Int J Reprod Biomed</source>. (<year>2023</year>) <volume>21</volume>(<issue>4</issue>):<fpage>277</fpage>&#x2013;<lpage>84</lpage>. <pub-id pub-id-type="doi">10.18502/ijrm.v21i4.13267</pub-id><pub-id pub-id-type="pmid">37260553</pub-id></citation></ref>
<ref id="B24"><label>24.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Malliou</surname><given-names>P</given-names></name><name><surname>Syrnioti</surname><given-names>A</given-names></name><name><surname>Koletsa</surname><given-names>T</given-names></name><name><surname>Karlafti</surname><given-names>E</given-names></name><name><surname>Karakatsanis</surname><given-names>A</given-names></name><name><surname>Raptou</surname><given-names>G</given-names></name><etal/></person-group> <article-title>Mucinous adenocarcinoma arising from a tailgut cyst: a case report</article-title>. <source>World J Clin Oncol</source>. (<year>2022</year>) <volume>13</volume>(<issue>10</issue>):<fpage>853</fpage>&#x2013;<lpage>60</lpage>. <pub-id pub-id-type="doi">10.5306/wjco.v13.i10.853</pub-id><pub-id pub-id-type="pmid">36337315</pub-id></citation></ref></ref-list>
</back>
</article>